Skip to main content
logo
Sinotherapeutics Inc. (SHA:688247)
China flag China · Delayed Price · Currency is CNY
9.50
-0.26 (-2.66%)
At close: Apr 9, 2026

Sinotherapeutics Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
127.761.0792.93134.92
Depreciation & Amortization
18.3623.2726.4326.94
Other Amortization
7.090.781.541.84
Loss (Gain) From Sale of Assets
--0.08-0.160.02
Asset Writedown & Restructuring Costs
-1.031.72-2.551.04
Loss (Gain) From Sale of Investments
-11-9.61-20.79-3.9
Stock-Based Compensation
---7.94
Provision & Write-off of Bad Debts
3.930.811.43-0.29
Other Operating Activities
-2.06-1.22-5.314.25
Change in Accounts Receivable
-25.28-2.18-42.77-6.61
Change in Inventory
-16.46-56.4713.83-0.05
Change in Accounts Payable
17.53-4.1112.6-52.23
Change in Other Net Operating Assets
16.63-3.03-3.533.69
Operating Cash Flow
130.2312.9673.18145.77
Operating Cash Flow Growth
905.01%-82.29%-49.80%-30.60%
Capital Expenditures
-94.93-38.96-176.34-16.01
Cash Acquisitions
---10.85-
Investment in Securities
-399.89-84.41-20-52.6
Other Investing Activities
10.9815.796.884.38
Investing Cash Flow
-483.84-107.57-200.31-64.23
Long-Term Debt Repaid
-0.07-0.16-0.92-0.93
Net Debt Issued (Repaid)
-0.07-0.16-0.92-0.93
Issuance of Common Stock
--389.93-
Repurchase of Common Stock
-36.15---
Common Dividends Paid
-27.88-28.11--
Other Financing Activities
---13.36-
Financing Cash Flow
-64.09-28.27375.65-0.93
Foreign Exchange Rate Adjustments
1.711.522.97-2.9
Net Cash Flow
-416-121.36251.577.71
Free Cash Flow
35.3-26-103.15129.77
Free Cash Flow Growth
----24.42%
Free Cash Flow Margin
6.90%-8.67%-41.67%41.13%
Free Cash Flow Per Share
0.08-0.06-0.240.32
Cash Income Tax Paid
5.131.289.171.1
Levered Free Cash Flow
-22.06-42.85-150.4430.86
Unlevered Free Cash Flow
-22.06-42.82-150.3131.01
Change in Working Capital
-12.76-63.78-20.34-26.98
Source: S&P Global Market Intelligence. Standard template. Financial Sources.